Adamantane derivatives as inhibitors of focal adhesion kinase

An adamantane derivative represented by formula 1 below, a pharmaceutically acceptable salt thereof, stereoisomer thereof, hydrate or solvate thereof:

• wherein in above formula 1,
• L1 and L2 are each independently a single bond, C1-10 alkylene, C2-10 alkenylene, C2-10 alkynylene, —N(Ra)—, —C(═O)—N(Ra)—, —N(Ra)—C(═O)—, —C(═O)—, —O—, —C(═O)—O—, —N(Ra)— C(═O)—O—, —N(Ra)—S(═O)—, —N(Ra)—S(═O)2—, —S(═O)(═N—Ra)—, or —S—;
• R1 and R2 are each independently C1-10 heterocycloalkylene, C3-10 cycloalkylene, C5-16 arylene or C4-10 heteroarylene;
• R3 is H, C1-10 alkyl, C2-10 alkenyl, —O—Ra, ═O, —NH—Ra, —NH(C═O)—Ra or C1-10 heterocycloalkyl;
• R4 is —O—Ra;
• R5 and R6 are each independently H or C1-10 alkyl;
• R7 is —CF3 or a halogen atom;
• Ra is H, —CF3 or C1-10 alkyl;
• and
• m, n, p and q are each independently 0 or 1.